Chapter reproduced from Valk PE, Bailey DL, Townsend DW, Maisey MN. Positron Emission Tomography: Basic Science and Clinical Practice. Springer-Verlag London Ltd 2003, 265–279.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford: Pergamon Press, 1991.
International Commission on Radiation Units and Measurements. Determination of Dose Equivalents Resulting from External Radiation Sources. ICRU Report No. 39. Bethesda, MD: ICRU, 1985.
Dillman LT. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. MIRD Pamphlet No. 4. J Nucl Med 1969;10(Supplement No.2).
Dillman LT. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation, Part 2. MIRD Pamphlet No. 6. J Nucl Med 1970;11(Supplement No.4).
International Commission on Radiation Units and Measurements. Radiation quantities and units. ICRU Report No. 33. Bethesda, MD: ICRU, 1980.
Groenewald W, Wasserman HJ. Constants for calculating ambient and directional dose equivalents from radionuclide point sources. Health Phys 1990; 58:655–8.
Delacroix D, Guerre JP, Leblanc P, Hickman C. Radionuclide and Radiation Protection Handbook 1998. Rad Prot Dosim 1998;76.
Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. New York: Society of Nuclear Medicine, 1988.
Stabin MG. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538–46. (The MIRDOSE program is available from the Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, PO Box 117, MS51, Oak Ridge, TN 37831-01117, USA.)
Snyder WS, Ford MR, Warner GG, Watson SB. Absorbed dose per unit cumulated activity for selected nuclides and organs. MIRD Pamphlet No.11. New York: Society of Nuclear Medicine, 1975.
International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals Addendum to ICRP53. ICRP Publication 80. Oxford: Pergamon Press, 1998.
International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Oxford: Pergamon Press, 1987.
Brihaye C, Depresseux JC, Comar D. Radiation dosimetry for bolus administration of oxygen-15 water. J Nucl Med 1995; 36:651–6.
Smith T, Tong C, Lammertsma AA et al. Dosimetry of intravenously administered oxygen-15 labelled water in man: a model based on experimental human data from 21 subjects. Eur J Nucl Med 1994; 21:1126–34.
Deloar HM, Watabe H, Nakamura T et al. Internal dose estimation including the nasal cavity and major airway for continuous inhalation of C15O2, 15O2 and C15O using the thermoluminescent method. J Nucl Med 1997; 38:1603–13.
Dowd MT, Chen C-T, Wendel MJ, Faulhaber PJ, Cooper MD. Radiation dose to the bladder wall from 2-[18F] fluoro-2-deoxy-Dglucose in adult humans. J Nucl Med 1991; 32:707–12.
Dhawan V, Belakhlef A, Robeson W, Ishikawa T, Margouleff C, Takikawa S, et al. Bladder wall radiation dose in humans from fluorine-18-FDOPA. J Nucl Med 1996;37(11):1850–2.
Hicks RJ, Binns D, Stabin MG. Pattern of uptake and excretion of [18F]-FDG in the lactating breast. J Nucl Med 2001; 42:1238–42.
Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environ Health Perspect 1997;105(suppl 6):1403–9. Also at www.orau.gov/ehsd/ridic.htm.
Stabin MG, Breitz HB. Breast milk excretion of radiopharmaceuticals: mechanisms, findings and radiation dosimetry. J Nucl Med 2000; 41:863–73.
Stabin MG, Watson EE, Cristy M et al. Mathematical models of the adult female at various stages of pregnancy. ORNL Report No. ORNL/TM-12907. Oak Ridge, TN: 1995.
Bohuslavizki KH, Kroger S, Klutmann S, Greiss-Tonshoff M, Clausen M. Pregnancy testing before high-dose radioiodine treatment: a case report. J Nucl Med Technol 1999; 27:220–1.
Watson EE. Radiation absorbed dose to the human foetal thyroid. In: Fifth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN: Oak Ridge Associated Universities, pp 179–87, 1992.
Almeida P, Bendriem B, de Dreuille O, Peltier A, Perrot C, Brulon V. Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters. Eur J Nucl Med 1998; 25:1435–41.
Huda W, Mergo PJ. How will the introduction of multi-slice CT affect patient doses? In: IAEA International Conference, Malaga 2001 Radiological Protection of Patients in Diagnostic and Interventional Radiology, Nuclear Medicine and Radiotherapy. Vienna: IAEA, 2001.
Thomson J, Tingey D. Radiation doses from computed tomography in Australia. Australian Radiation Laboratory Report ARL/TR123. Canberra: Australian Government Department of Health and Aged Care, 1997.
Paediatric Task Group of European Association of Nuclear Medicine. A radiopharmaceuticals schedule for imaging in paediatrics. Eur J Nucl Med 1990; 17:127–9.
Towson J, Smart R. Radiopharmaceutical activities administered for paediatric nuclear medicine procedures in Australia. Radiation Protection in Australasia 2000; 17:110–20.
International Commission on Radiological Protection. Radiological Protection in Biomedical Research. ICRP Publication 62. Oxford: Pergamon Press, 1991.
Bloe F, Williams A. Personnel monitoring observations. J Nucl Med Technol 1995; 23:82–6.
Chiesa C, De Sanctis V, Crippa F et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67 and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1997; 24:1380–9.
Kearfott KJ, Carey JE, Clemenshaw MN, Faulkner DB. Radiation protection design for a clinical positron emission tomography imaging suite. Health Phys 1992; 63:581–9.
Benatar NA, Cronin BF, O’Doherty M. Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas. Eur J Nucl Med 2000; 27:583–9.
Bixler A, Springer G, Lovas R. Practical aspects of radiation safety for using fluorine-18. J Nucl Med Technol 1999; 27:14–16.
Brown TF, Yasillo NJ. Radiation safety considerations for PET centers. J Nucl Med Technol 1997; 25:98–102.
Dell MA. Radiation safety review for 511-keV emitters in nuclear medicine. J Nucl Med Technol 1997; 25:12–17.
Bailey DL, Young H, Bloomfield PM et al. ECAT ART — a continuously rotating PET camera: performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department. Eur J Nucl Med 1997; 24:6–15.
Cronin B, Marsden PK, O’Doherty MJ. Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies? Eur J Nucl Med 1999; 26:121–8.
McCormick VA, Miklos JA. Radiation dose to positron emission tomography technologists during quantitative versus qualitative studies. J Nucl Med 1993; 34:769–72.
McElroy NL. Worker dose analysis based on real time dosimetry. Health Phys 1998; 74:608–9.
Bird NJ, Barber RW, Turner KB, Meara S. Radiation doses to staff during gamma camera PET [abst]. Nucl Med Commun 1999; 20:471.
Towson J, Brackenreg J, Kenny P, Constable C, Silver K, Fulham M. Analysis of external exposure to PET technologists [abstr]. Nucl Med Commun 2000; 21:497.
Eberl SE, Anayat AA, Fulton RR, Hooper PK, Fulham MJ. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur J Nucl Med 1997; 24:299–304.
Griff M, Berthold T, Buck A. Radiation exposure to sonographers from fluorine-18-FDG PET patients. J Nucl Med Technol 2000; 28:186–7.
Council of the European Union. Council Directive 96/29/Euratom on basic safety standards for the protection of the health of workers and the general public. Official J Eur Commun 1996; L159:1–114.
Zimmerman BE, Kubicek GJ, Cessna JT, Plascjak PS, Eckelman WC. Radioassays and experimental evaluation of dose calibrator settings for 18F. Applied Radiation & Isotopes 2001; 54:113–22.
Cember H. Introduction to Health Physics (3rd ed). New York: McGraw-Hill, 1996.
Courtney J, Mendez P, Hidalgo-Salvatierra O, Bujenovic S. Photon shielding for a positron emission tomography suite. Health Phys 2001;81(Supplement):S24–8.
Schleien B (ed). The Health Physics and Radiological Health Handbook, 2nd edn. Silver Spring MD: Scinta Inc, 1992.
Negin C, Worku G. Microshield version 4.0: A microcomputer code for shielding analysis and dose assessment. Rockville MD: Grove Engineering, Inc.; 1992.
Wachsmann F, Drexler G. Graphs and Tables for Use in Radiology. Berlin: Springer-Verlag, 1976.
Deloar H, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M et al. Estimation of internal absorbed dose of L-[methyl-11C] methionine using whole-body positron emission tomography. Eur J Nucl Med 1998; 25:629–33.
Wrobel MC, Carey JE, Sherman PS, Kilbourn MR. Simplifying the dosimetry of carbon-11-labelled radiopharmaceuticals. J Nucl Med 1997;38(4):654–60.
Herzog H, Seitz R, Tellmann L et al. Pharmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans. Eur J Nucl Med 1994; 1:138–43.
Brown WD, Oakes TR, DeJesus OT, Taylor MD, Roberts AD, Nickles RJ, et al. Fluorine-18-Fluoro-L-DOPA dosimetry with carbidopa pretreatment. J Nucl Med 1998;39(11):1884–91.
Graham MM, Peterson LM, Link JM, Evans ML, Rasey JS, Koh W-J, et al. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. J Nucl Med 1997;38(10):1631–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Towson, J.E.C. (2005). Radiation Dosimetry and Protection in PET. In: Bailey, D.L., Townsend, D.W., Valk, P.E., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London. https://doi.org/10.1007/1-84628-007-9_12
Download citation
DOI: https://doi.org/10.1007/1-84628-007-9_12
Publisher Name: Springer, London
Print ISBN: 978-1-85233-798-8
Online ISBN: 978-1-84628-007-8
eBook Packages: MedicineMedicine (R0)